31.07.2013 • NewsDede WillamsH1 resultsJim Gallogly

LyondellBasell Boosted by U.S. Polyolefins Business in Q2

In Q2 2013, sales of Rotterdam-based petrochemical and plastics giant LyondellBasell weakened by 1.3% year-on-year to $11.1 billion but improved by 4% against Q1 2013. EBITDA declined by 4% year-on-year, while increasing by the same margin against Q1. A strong performance by the US-based olefins and polyolefins segment is largely credited for the positive results. Business in Europe and Asia was better than expected, but CEO Jim Gallogly warned that pricing conventions and maintenance turnarounds at competitors had boosted quarterly figures. "Underlying fundamentals within Europe remain weak," he said. 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read